Albanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hepatitis/ethet

Lidhja ruhet në kujtesën e fragmenteve
15 rezultatet

Treatment of hepatitis C using hyperthermia

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION This invention relates to hyperthermic treatment of hepatitis C. BACKGROUND OF THE INVENTION Injected drug users are the largest group of people with hepatitis C infection. People who received a blood transfusion or kidney transplant before a diagnostic test became available

Treatment of hepatitis C using hyperthermia

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION This invention relates to hyperthermic treatment of hepatitis C. BACKGROUND OF THE INVENTION Injected drug users are the largest group of people with hepatitis C infection. People who received a blood transfusion or kidney transplant before a diagnostic test became available

Treatment of hepatitis C using hyperthermia

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION This invention relates to hyperthermic treatment of hepatitis C. BACKGROUND OF THE INVENTION Injected drug users are the largest group of people with hepatitis C infection. People who received a blood transfusion or kidney transplant before a diagnostic test became available
BACKGROUND OF THE INVENTION The invention relates generally to the use of sesquiterpene lactones in the treatment of infections caused by Flaviviridae and, more specifically, to the use of sesquiterpene lactone endoperoxides to treat hepatitis C infections, yellow fever, dengue fever, bovine viral

Inhibition and treatment of Hepatitis B virus and Flavivirus by Helioxanthin and its analogs

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION This invention relates to the anti-viral drugs such as Helioxanthin and its analogs compounds. These compounds may be used alone or in combination with other drugs for the treatment of the following: Hepatitis B virus (HBV), Hepatitis C virus (HCV), Yellow Fever, Dengue Virus,

Compound WS 727713

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
TECHNICAL FIELD The present invention relates to a new compound which is useful as a medicament or a cosmetic, to a process for producing the same and to a pharmaceutical composition comprising the same. BACKGROUND ART The melanocortin (MC) is a group of peptide hormones that are derived from

Multivalent vaccine composition having increased stability of capsular polysaccharide

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The present invention relates in particular to a stabilized bivalent hepatitis A/typhoid fever (HA-Vi) immunization composition in which the Vi valence conserves its immunogenic power for at least 24 months approximately. Hepatitis A and typhoid fever are two diseases for which a vaccine already

Methods for real-time multiplex isothermal detection and identification of bacterial, viral, and protozoan nucleic acids

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
SEQUENCE LISTING The sequence listing contained in the electronic file "2016-05-01 1464.8005_ST25.txt" created on May 2, 2016, comprising 60 KB is incorporated herein by reference". FIELD OF THE INVENTION This disclosure relates to rapid methods for real-time multiplex detection and identification

Use of a quinazoline compound in preparing a medicament against flaviviridae virus

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
This application is the U.S. national phase of International Application No. PCT/CN2011/083357 filed 2 Dec. 2011 which designated the U.S. and claims priority to CN 201010581618.3 filed 9 Dec. 2010, the entire contents of each of which are hereby incorporated by reference. TECHNICAL FIELD The

Modified fluorinated nucleoside analogues

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION The present invention includes (2'R)-2'-deoxy-2'-fluoro-2'-C-methyl nucleosides having the natural .beta.-D configuration and methods for the treatment of Flaviviridae infections, especially hepatitis C virus (HCV). BACKGROUND OF THE INVENTION Hepatitis C virus (HCV) infection

Modified fluorinated nucleoside analogues

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION The present invention includes (2'R)-2'-deoxy-2'-fluoro-2'-C-methyl nucleosides having the natural .beta.-D configuration and methods for the treatment of Flaviviridae infections, especially hepatitis C virus (HCV). BACKGROUND OF THE INVENTION Hepatitis C virus (HCV) infection

Modified fluorinated nucleoside analogues

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION The present invention includes (2'R)-2'-deoxy-2'-fluoro-2'-C-methyl nucleosides having the natural .beta.-D configuration and methods for the treatment of Flaviviridae infections, especially hepatitis C virus (HCV). BACKGROUND OF THE INVENTION Hepatitis C virus (HCV) infection

2'-Ethynyl nucleoside derivatives for treatment of viral infections

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION This invention is directed to novel compounds which are useful in the treatment of viral infections. The invention is also directed to pharmaceutical compositions containing the compounds, processes for their preparation and uses of the compounds in various medicinal

2'-ethynyl nucleoside derivatives for treatment of viral infections

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION This invention is directed to novel compounds which are useful in the treatment of viral infections. The invention is also directed to pharmaceutical compositions containing the compounds, processes for their preparation and uses of the compounds in various medicinal

RNA virus vaccines and methods

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not Applicable. BACKGROUND The unstable nature of the RNA molecule enables RNA viruses to evolve far more rapidly than DNA viruses, frequently changing their surface structures. RNA viruses in general have very high mutation rates as
Bashkohuni në faqen
tonë në facebook

Baza e të dhënave më e plotë e bimëve medicinale e mbështetur nga shkenca

  • Punon në 55 gjuhë
  • Kurime bimore të mbështetura nga shkenca
  • Njohja e bimëve nga imazhi
  • Harta GPS interaktive - etiketoni bimët në vendndodhje (së shpejti)
  • Lexoni botime shkencore në lidhje me kërkimin tuaj
  • Kërkoni bimë medicinale nga efektet e tyre
  • Organizoni interesat tuaja dhe qëndroni në azhurnim me kërkimet e lajmeve, provat klinike dhe patentat

Shkruani një simptomë ose një sëmundje dhe lexoni në lidhje me barërat që mund të ndihmojnë, shtypni një barishte dhe shikoni sëmundjet dhe simptomat që përdoren kundër.
* I gjithë informacioni bazohet në kërkimin shkencor të botuar

Google Play badgeApp Store badge